Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin versus Microrelin in girls with central precocious puberty
IRCT20250430065533N1Phase 4Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of leuprolide and triptorelin in central precocious puberty (CPP) (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Uterine size and volume, Ovarian size and volume and 6 more. Started Aug 2025; status: completed.
02
Drugs
leuprolidetriptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on IRCT20250430065533N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250430065533N1.